TrialInvestigational new drugs2017

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors.

Tetsuhide Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.